Calcium-D-Sandoz 20 effervescent tablets

Sandoz

$45.50

Compensation for a vitamin D3 and calcium deficiency that occurs at the same time.

For the substitution of vitamin D3 and calcium in addition to a specific treatment of osteoporosis in patients who have been diagnosed as having concomitant calcium and vitamin D3 deficiencies or who are at high risk of such deficiencies.

Contraindications

Hypersensitivity to the active substances, soybean, peanut or any of the listed in section 6.1. mentioned other ingredients
Hypercalcämie, Hypercalcurie
Kidney limestones, nephrocalcinosis
Diseases and/or conditions resulting in hypercalcaemia and/or hypercalcuria (primary hyperparathyroidism, myeloma, bone metastases)
Vitamin D3 overdose
renal dysfunction

interactions

Concomitant use of phenytoin and other barbiturates may decrease the effect of vitamin D3 due to increased metabolism.
Thiazide diuretics reduce urinary calcium excretion. Because of the increased risk of hypercalcaemia, regular monitoring of serum calcium levels is recommended when thiazide diuretics are used concomitantly.
Systemic corticosteroids decrease calcium absorption. During concomitant use it may be necessary to increase the dose of Calcium-D-Sandoz.
Concomitant treatment with ion exchange resins such as cholestyramine or laxatives such as paraffin oil can reduce gastrointestinal absorption of vitamin D. Therefore, as long a time interval as possible between doses should be recommended.
Calcium carbonate can impede the absorption of tetracycline preparations taken at the same time. For this reason, tetracycline supplements should be taken at least two hours before or four to six hours after oral calcium intake.
Hypercalcaemia may increase the toxicity of cardiac glycosides during treatment with calcium and vitamin D. Medical control, including ECG examination and control of serum calcium levels, is required.
When combined with bisphosphonates or sodium fluoride, these preparations should be taken at least three hours before Calcium-D-Sandoz, otherwise the gastrointestinal absorption of bisphosphonates may be reduced.
Oxalic acid (eg, in spinach and rhubarb) and phytic acid (found in whole grains) can inhibit calcium absorption by forming insoluble compounds with calcium ions. The patient should not take calcium supplements within two hours before or after eating foods containing high doses of oxalic or phytic acid

Pregnancy
Vitamin D and calcium deficiencies that occur simultaneously during pregnancy and breastfeeding can be compensated for. The amount taken daily must not exceed 1500 mg calcium and 600 IU vitamin D3. The daily dose must therefore not be more than one tablet.

In animal studies, overdoses of vitamin D have shown teratogenic effects.

During pregnancy, an overdose of vitamin D3 must be avoided, since the resulting long-term hypercalcaemia can lead to physical and mental retardation, supravalvular aortic stenosis and retinopathy in the child.

However, there are also some case reports of administration of very high doses of vitamin D in maternal hypoparathyroidism giving birth to healthy children.

Breastfeeding
Calcium-D-Sandoz effervescent tablets can be used while breastfeeding. Calcium passes into breast milk in small amounts without having a negative effect on the child.

Vitamin D and its metabolites are also excreted in breast milk. This should be taken into account when giving the child extra vitamin D.

Pregnant women and nursing mothers should take the calcium preparation 2 hours apart from meals because of the possible reduction in iron absorption.

application

Dosage
Adults and older people:
1 - 2 effervescent tablets daily (equivalent to 600-1200 mg calcium and 400-800 IU vitamin D3). Patients with hepatic impairment: No dose adjustment necessary.

Patients with impaired renal function:
Calcium-D-Sandoz must not be used in patients with severe renal impairment.

Method of
administration For oral use.
The effervescent tablet is dissolved in a glass of water (approx. 200 ml) and drunk immediately.

side effects

The drug can cause hypersensitivity reactions including rash, itching, hives and other systemic allergic reactions including anaphylactic reactions, facial edema, angioneurotic edema. Uncommon cases of hypercalcaemia, hypercalciuria have been observed and rare cases of gastrointestinal disorders such as nausea, diarrhoea, abdominal pain, constipation, flatulence, abdominal distension and vomiting have been reported.

All side effects are categorized by body system and frequency as follows:

Very common: ≥1 /10
Common: ≥1/100 to <1/10
Uncommon: ≥1/1,000 to <1/100
Rare: ≥1/10,000 to <1/1,000
Very rare: <1/10,000
Not known: (cannot be estimated from the available data)

Immune system disorders
Very rare: Hypersensitivity reactions such as Quincke's edema or laryngeal edema

Metabolism and nutrition disorders
Uncommon: hypercalcaemia, hypercalcuria
Not known: milk-alkali syndrome

Gastrointestinal disorders
Rare: nausea, diarrhoea, abdominal pain, constipation, flatulence, abdominal distension
Not known: vomiting

Skin and subcutaneous tissue disorders
Rare: rash, pruritus, urticaria.

Special patient groups: Impaired renal function
Patients with impaired have an increased risk of hyperphosphatemia, kidney stones and nephrocalcinosis.

composition

The active ingredients are calcium carbonate and vitamin D3.

The other ingredients are:
Anhydrous citric acid, malic acid, sodium bicarbonate, sodium cyclamate, lemon flavor (contains: lemon oil, mannitol, sorbitol, dextrin, D-glucono-1,5-lactone, gum arabic), sodium carbonate, maltodextrin, sodium saccharin, sucrose, Gelatin, corn starch, partially hydrogenated soybean oil, alpha-tocopherol.

Your order will be shipped within 3-4 business days